Image-guided pre-operative magnetic seed localization of breast lesions: Experience of a Northern Ontario hospital with the Magnetic Occult Lesion Localization Instrument (MOLLI) MOLLI seed localization
Abstract
Background: Breast cancer remains one of the leading malignancies among Canadian women. Lumpectomies have been increasing in numbers over total mastectomies due to comparable survival rates and lower reoperation rates. While wire localization has been the traditional method for the localization of non-palpable breast lesions, it presents logistical and patient comfort challenges. Magnetic localization systems, such as the Magnetic Occult Lesion Localization Instrument (MOLLI), offer an alternative with potential advantages.
Methods: A retrospective review was conducted, examining the outcomes of 145 patients who underwent MOLLI seed localization between December 2023 and October 2024. A total of 154 seeds were placed, with localization performed predominantly via sonographic guidance. The primary outcomes were placement success, retrieval rates, margin status of the surgical specimens and number of days between seed placement and surgical excision.
Results: The mean patient age was 62 years. MOLLI seeds were successfully placed in 100% of cases, with 76% within or adjacent to the lesion. Of the exisced lesions, 70.3% were malignant with a positive margin rate of 17.3%, which was defined as invasive carcinoma or ductal carcinoma in situ (DCIS) being less than 2mm from the margins. The MOLLI seeds were successfully retrieved in 100% of cases.
Conclusion: The MOLLI localization system demonstrated high accuracy and retrieval success, offering a viable alternative to traditional wire localization. The findings suggest MOLLI and other magnetic localizers may improve lesion localization and excision while also improving patient comfort. As a retrospective single-center study, further large-scale trials are needed to confirm generalizability.
Full text article
References
Brenner DR, Gillis J, Demers AA, et al. Projected estimates of cancer in Canada in 2024. Can Med Assoc J. 2024;196(18):E615-E623. doi:10.1503/cmaj.240095
Morrow M, Abrahamse P, Hofer TP, et al. Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Management. JAMA Oncol. 2017;3(10):1352. doi:10.1001/jamaoncol.2017.0774
Nelson JA, Rubenstein RN, Haglich K, et al. Analysis of a Trend Reversal in US Lumpectomy Rates From 2005 Through 2017 Using 3 Nationwide Data Sets. JAMA Surg. 2022;157(8):702. doi:10.1001/jamasurg.2022.2065
Fisher B, Anderson S, Bryant J, et al. Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer. N Engl J Med. 2002;347(16):1233-1241. doi:10.1056/NEJMoa022152
Agarwal S, Pappas L, Neumayer L, Kokeny K, Agarwal J. Effect of Breast Conservation Therapy vs Mastectomy on Disease-Specific Survival for Early-Stage Breast Cancer. JAMA Surg. 2014;149(3):267. doi:10.1001/jamasurg.2013.3049
De Boniface J, Szulkin R, Johansson ALV. Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status: A Swedish National 6-Year Follow-up of 48 986 Women. JAMA Surg. 2021;156(7):628. doi:10.1001/jamasurg.2021.1438
Chu QD, Hsieh MC, Yi Y, Lyons JM, Wu XC. Outcomes of Breast-Conserving Surgery Plus Radiation vs Mastectomy for All Subtypes of Early-Stage Breast Cancer: Analysis of More Than 200,000 Women. J Am Coll Surg. 2022;234(4):450-464. doi:10.1097/XCS.0000000000000100
Norman C, Lafaurie G, Uhercik M, Kasem A, Sinha P. Novel wire‐free techniques for localization of impalpable breast lesions—A review of current options. Breast J. 2021;27(2):141-148. doi:10.1111/tbj.14146
Banys-Paluchowski M, Kühn T, Masannat Y, et al. Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411). Cancers. 2023;15(4):1173. doi:10.3390/cancers15041173
Cheung BHH, Co M, Lui TTN, Kwong A. Evolution of localization methods for non-palpable breast lesions: a literature review from a translational medicine perspective. Transl Breast Cancer Res. 2024;5:12-12. doi:10.21037/tbcr-23-49
Davis P, Wechsler R, Feig S, March D. Migration of breast biopsy localization wire. Am J Roentgenol. 1988;150(4):787-788. doi:10.2214/ajr.150.4.787
Pavlicek W, Walton HA, Karstaedt PJ, Gray RJ. Radiation Safety With Use of I-125 Seeds for Localization of Nonpalpable Breast Lesions. Acad Radiol. 2006;13(7):909-915. doi:10.1016/j.acra.2006.03.017
Hayes MK. Update on Preoperative Breast Localization. Radiol Clin North Am. 2017;55(3):591-603. doi:10.1016/j.rcl.2016.12.012
Gera R, Tayeh S, Al-Reefy S, Mokbel K. Evolving Role of Magseed in Wireless Localization of Breast Lesions: Systematic Review and Pooled Analysis of 1,559 Procedures. Anticancer Res. 2020;40(4):1809-1815. doi:10.21873/anticanres.14135
Depretto C, Della Pepa G, De Berardinis C, et al. Magnetic Localization of Breast Lesions: A Large-Scale European Evaluation in a National Cancer Institute. Clin Breast Cancer. 2023;23(8):e491-e498. doi:10.1016/j.clbc.2023.08.004
Look Hong N, Wright FC, Semple M, Nicolae AM, Ravi A. Results of a phase I, non-randomized study evaluating a Magnetic Occult Lesion Localization Instrument (MOLLI) for excision of non-palpable breast lesions. Breast Cancer Res Treat. 2020;179(3):671-676. doi:10.1007/s10549-019-05499-z
Price ER, Khoury AL, Esserman LJ, Joe BN, Alvarado MD. Initial Clinical Experience With an Inducible Magnetic Seed System for Preoperative Breast Lesion Localization. Am J Roentgenol. 2018;210(4):913-917. doi:10.2214/AJR.17.18345
Micha AE, Sinnett V, Downey K, et al. Patient and clinician satisfaction and clinical outcomes of Magseed compared with wire-guided localisation for impalpable breast lesions. Breast Cancer. 2021;28(1):196-205. doi:10.1007/s12282-020-01149-1
Dave RV, Barrett E, Morgan J, et al. Wire- and magnetic-seed-guided localization of impalpable breast lesions: iBRA-NET localisation study. Br J Surg. 2022;109(3):274-282. doi:10.1093/bjs/znab443
Kurita T, Taruno K, Nakamura S, et al. Magnetically Guided Localization Using a Guiding-Marker System® and a Handheld Magnetic Probe for Nonpalpable Breast Lesions: A Multicenter Feasibility Study in Japan. Cancers. 2021;13(12):2923. doi:10.3390/cancers13122923
Struik GM, Schermers B, Mares I, et al. Randomized controlled trial comparing magnetic marker localization (MaMaLoc) with wire‐guided localization in the treatment of early‐stage breast cancer. Breast J. 2021;27(8):638-650. doi:10.1111/tbj.14262
Shirazi S, Hajiesmaeili H, Khosla M, Taj S, Sircar T, Vidya R. Comparison of Wire and Non-Wire Localisation Techniques in Breast Cancer Surgery: A Review of the Literature with Pooled Analysis. Medicina (Mex). 2023;59(7):1297. doi:10.3390/medicina59071297
Kelly BN, Webster AJ, Lamb L, et al. Magnetic Seeds: An Alternative to Wire Localization for Nonpalpable Breast Lesions. Clin Breast Cancer. 2022;22(5):e700-e707. doi:10.1016/j.clbc.2022.01.003
Redfern RE, Shermis RB. Initial Experience Using Magseed for Breast Lesion Localization Compared With Wire-Guided Localization: Analysis of Volume and Margin Clearance Rates. Ann Surg Oncol. 2022;29(6):3776-3783. doi:10.1245/s10434-022-11327-4
Zacharioudakis K, Down S, Bholah Z, et al. Is the future magnetic? Magseed localisation for non palpable breast cancer. A multi-centre non randomised control study. Eur J Surg Oncol. 2019;45(11):2016-2021. doi:10.1016/j.ejso.2019.06.035
Kabeer KK, Gowda SM, Mohd-Isa Z, et al. An Audit on Oncological Safety with Magseed Localised Breast Conserving Surgery. Indian J Surg Oncol. 2022;13(3):616-621. doi:10.1007/s13193-022-01531-9
Liang DH, Black D, Yi M, et al. Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of Non-palpable Breast Lesions. Ann Surg Oncol. 2022;29(6):3822-3828. doi:10.1245/s10434-022-11443-1
Ontario Health. Wire-free, nonradioactive localization techniques to guide surgical excision of nonpalpable breast tumours: a health technology assessment. Ont Health Technol Assess Ser [Internet]. 2023 May;23(2):1–139. Available from: hqontario.ca/evidence-to-improve-care/healthtechnology-assessment/reviews-and-recommendations/wire-free-nonradioactive-localizationtechniques-to-guide-surgical-excision-of-nonpalpable-breast-tumours.
Jordan RM, Rivera-Sanchez L, Kelley K, et al. The Impact of an Electromagnetic Seed Localization Device Versus Wire Localization on Breast-Conserving Surgery: A Matched-Pair Analysis. Ann Surg Oncol. 2023;30(7):4111-4119. doi:10.1245/s10434-023-13366-x
Davey MG, O’Donnell JPM, Boland MR, et al. Optimal localization strategies for non-palpable breast cancers –A network meta-analysis of randomized controlled trials. The Breast. 2022;62:103-113. doi:10.1016/j.breast.2022.02.004
Authors
Copyright (c) 2025 Archives of Breast Cancer
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright©. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International License, which permits copy and redistribution of the material in any medium or format or adapt, remix, transform, and build upon the material for any purpose, except for commercial purposes.